Apixaban vs Pembrolizumab

## Apixaban vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Apixaban** and **Pembrolizumab**.

## Mechanism of Action

**Apixaban**: Direct Factor Xa inhibitor.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Apixaban — 12 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Apixaban — C25H25N5O4; Pembrolizumab — N/A.

**Molecular Weight**: Apixaban — 459.4970 g/mol; Pembrolizumab — N/A.

**Type**: Apixaban — Small molecule; Pembrolizumab — Antibody.